|
2023
|
Invention
|
Methods for treating agitation in subjects with mild cognitive impairment or major neurocognition... |
|
|
Invention
|
Radiolabelled mgl pet ligands.
The present invention relates to novel, selective, radiolabelled ... |
|
|
Invention
|
P2x7 modulators.
The present invention is directed to compounds of Formulas (I, IIa and IIb):
... |
|
|
Invention
|
Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibi... |
|
|
Invention
|
Compounds and uses thereof.
The present invention features compounds useful in the treatment of ... |
|
|
Invention
|
Long-acting formulations. This invention concerns pharmaceutical compositions for administration ... |
|
|
G/S
|
Pharmaceutical preparations for human use. |
|
|
Invention
|
Aryl piperidines as monoacylglycerol lipase modulators.
Aryl piperidine compounds of Formula (I)... |
|
|
Invention
|
Methods of treating prostate cancer.
Disclosed are methods of treating prostate cancer by admini... |
|
|
Invention
|
Mass spectroscopy assay for detecting o-beta-linked n-acetylglucosaminylated tau peptides. OOOO-G... |
|
|
Invention
|
Use of milvexian for treating or preventing ischemic stroke. A Factor XIa inhibitor having therap... |
|
|
Invention
|
Modulation of a lncrna in the treatment of hiv. Described are modulators of function and/or expre... |
|
|
Invention
|
Cyclic peptide inhibitors of il-23. The present invention relates to novel cyclic peptide inhibit... |
|
|
Invention
|
Inhibitors of coronavirus. aa]pyrazine amide compounds) for treating and/or preventing infection ... |
|
|
Invention
|
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptors.
The presen... |
|
|
Invention
|
Fgfr2 inhibitors for the treatment of cholangiocarcinoma.
Disclosed herein are methods of treati... |
|
|
Invention
|
Blood-based screening of subjects for a clinical trial for treatment of tauopathy or amyloidogeni... |
|
|
Invention
|
Protein predictors for lung cancer. Disclosed herein are methods for analyzing predictors includi... |
|
|
Invention
|
Collaborative frameworks for improving regulatory decision-making of measurement solutions. In an... |
|
|
Invention
|
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators.
Disubstituted octah... |
|
|
Invention
|
Monoacylglycerol lipase modulators.
3.1.0 and 4.1.0 Azabicycle compounds of Formula (I), pharmac... |
|
|
Invention
|
Bedaquiline for use in the treatment of leprosy. The present invention relates to a new use of be... |
|
|
Invention
|
Methods for mitigating lung injury in conjunction with exposure to radiation and/or radiation or ... |
|
|
Invention
|
Pyrrolidinone derivatives as inhibitors of nf-κb inducing kinase. The present disclosure relates ... |
|
|
Invention
|
Pyrrolidione derivatives as inhibitors of nf kappa b inducing kinase. The present disclosure rela... |
|
|
Invention
|
Pyrrolidinone derivatives as inhibitors of nf kappa b inducing kinase. The present disclosure rel... |
|
|
Invention
|
System and method for detecting cognitive decline using speech analysis.
System and method for d... |
|
|
Invention
|
Imidazopyridazines as modulators of il-17.
The present application discloses compounds having th... |
|
|
Invention
|
System and method for assessing cognitive and mood states of a real world user as a function of v... |
|
|
Invention
|
Package |
|
|
Invention
|
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y recep... |
|
2022
|
G/S
|
Human pharmaceutical preparations for the prevention and
treatment of viral diseases, auto-immun... |
|
|
Invention
|
Formulations/compositions comprising a btk inhibitor.
Disclosed are formulations/compositions co... |
|
|
Invention
|
Modified oligonucleotides for use in treatment of tauopathies.
Oligonucleotides comprising modif... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer for
human use. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of multiple
sclerosis. |
|
|
G/S
|
Vaccines. |
|
|
G/S
|
Human pharmaceutical preparations for the prevention and
treatment of oncological diseases and d... |
|
|
Invention
|
4-alkoxy-6-oxo-pyridazine derivatives modulating nlrp3.
The invention relates to novel compounds... |
|
|
G/S
|
Pharmaceutical preparations for human purposes. |
|
2021
|
Invention
|
Tricyclic pyrimidines as cyclin-dependent kinase 7 (cdk7) inhibitors.
The invention relates to p... |
|
|
Invention
|
Branched macrocyclic 4-(pyrazol-5-yl)-indole derivatives as inhibitors of mcl-1.
The present inv... |
|
|
Invention
|
Macrocyclic branched 3-fluoro-but-3-enamides as inhibitors of mcl-1.
The present invention relat... |
|
|
G/S
|
Vaccines. Providing information in the field of vaccines. |
|
|
Invention
|
Small molecule inhibitors of nf-kb inducing kinase.
This invention relates to compounds of Formu... |
|
|
G/S
|
Downloadable mobile application designed to electronically scan and track pharmaceutical preparat... |
|
|
G/S
|
Downloadable mobile application designed to electronically
scan and track product assets for pur... |
|
|
Invention
|
Process toward the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phen... |
|
|
Invention
|
Cyclin-dependent kinase 7 (cdk7) non-covalent inhibitors.
The invention relates to pharmaceutica... |
|
|
Invention
|
New compound.
The invention relates to novel compounds for use as inhibitors of NLRP3 inflammaso... |
|
|
Invention
|
New compound.
The invention relates to novel compounds for use as inhibitors of NL-RP3 inflammas... |
|
|
Invention
|
Drug delivery devices with reusable components and disposable components.
Various exemplary drug... |
|
|
Invention
|
Drug delivery devices with a multi-dispensing head.
Various exemplary drug delivery devices with... |
|
|
Invention
|
Drug delivery devices with propellant.
Various exemplary drug delivery devices with propellant, ... |
|
|
Invention
|
Pharmaceutical ingredient mixing training device |
|
|
Invention
|
Long-acting formulations.
This invention concerns pharmaceutical compositions for administration... |
|
2020
|
Invention
|
Hexahydro-5,8-epoxycyclohepta[c]pyrazole derivatives useful as modulators of the cb1 and / or cb2... |
|
|
Invention
|
Macrocyclic spirocycle derivatives as mcl-1 inhibitors.
The present invention relates to pharmac... |
|
|
Invention
|
Antiviral nucleosides and derivatives thereof.
Disclosed herein are nucleoside compounds and der... |
